Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Summary of Accrued Expenses (Details)

v3.10.0.1
Accrued Expenses - Summary of Accrued Expenses (Details) - USD ($)
Dec. 31, 2018
Mar. 31, 2018
Payables and Accruals [Abstract]    
Vendors- clinical trials $ 497,577
Professional fees 67,420 492,250
Income taxes payable 154,300 154,300
Employee salaries and benefits 34,337 104,110
Due to former owners, related to acquisition 34,268 33,124
Other 34,274 9,525
Accrued expenses, Total $ 324,599 $ 1,290,886